The effect of short term treatment with probiotic VSL#3 on various clinical and biochemical parameters in patients with liver cirrhosis

• Autorzy: Marlicz W. , Wunsch E. , Mydlowska M. , Milkiewicz M. , Serwin K. , Mularczyk M. , Milkiewicz P. , Raszeja-Wyszomirska J.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

liver cirrhosis; probiotic; patient; portal hypertension; chemokine; plasma level; interleukin 6; vascular endothelial growth factor; plasminogen activator inhibitor; monocyte chemotactic protein; myeloperoxidase; nitric oxide; prostaglandin; thromboxane B2; endotoxin

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2016
• Tom: 67
• Numer: 6
• Opis fizyczny: p.867-877,fig.,ref.

Twórcy

autor

Marlicz W.

• Department of Gastroenterology, Pomeranian Medical University, 1 Unii Lubelskiej Street, 71-252 Szczecin, Poland

autor

Wunsch E.

• Translational Medicine Group Pomeranian Medical University, Szczecin, Poland

autor

Mydlowska M.

• Translational Medicine Group Pomeranian Medical University, Szczecin, Poland

autor

Milkiewicz M.

• Department of Medical Biology, Pomeranian Medical University, Szczecin, Poland

autor

Serwin K.

• Department of Physiology, Pomeranian Medical University, Szczecin, Poland

autor

Mularczyk M.

• Department of Human Anatomy, Pomeranian Medical University, Szczecin, Poland

autor

Milkiewicz P.

• Translational Medicine Group Pomeranian Medical University, Szczecin, Poland
• Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland

autor

Raszeja-Wyszomirska J.

• Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland